A Study of GDC-0575 Alone and in Combination With Gemcitabine in Participants With Refractory Solid Tumors or Lymphoma

Clinical trial NCT01564251 · COMPLETED

Trial details

NCT number: NCT01564251
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, Solid Tumor

Start date: 2012-03-23
Primary completion: 2018-01-11
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.